CellGenix is proud to announce that Miriam Ramirez Dominguez was awarded the CellGenix stipend for the novel Master program in Manufacturing of Advanced Therapy Medicinal Products.

Miriam will specialize as Qualified Person as this will allow her to work as a Technical Director in a GMP Facility, the next step in her career.

We wish her every succes in taking the master program!



Miriam Ramirez-Dominguez, PhD is a Senior Researcher in the field of Advanced Therapies.  Her PhD thesis was the first one in Spain (2007) about mouse embryonic stem cells reprogramming.

Immediately after graduation, she joined the Diabetes Research Center of the University of Miami (USA), to perform PostDoctoral studies in cell, molecular and genic strategies of differentiation of fetal and adult human stem cells.

 In 2009 she joined the Program in Diabetes and Endocrinology in UPV, Bilbao (Spain) to set up and direct the Laboratory of Cell Therapy in Diabetes.  Later, she worked as a Senior Researcher both at the Beta Cell Bank of the University Hospital Brussels and the Cell Therapy Unit of the JDRF Diabetes Research Center at the Vrije Universiteit Brussel (VUB, Brussels, Belgium). There, she worked in the manufacturing of human pancreatic islets to be transplanted in diabetic patients as well as in the optimization of Human Islet Isolation procedures.  Besides, she participated in the design of preclinical and clinical approaches for transplantation of different beta cell sources in ectopic places. Therefore, her work has been a bridge between preclinical and clinical trials in the field of Type 1 Diabetes.



With recent commercial approvals of the first cell therapies, new treatments have entered the market with manufacturing processes that differ greatly from standard pharmaceutical products. In May 2018 new Guidelines on Good Manufacturing Practice (GMP) specific for Advanced Therapy Medicinal Products (ATMPs) came into force in Europe. The demand for specialists in process development, manufacturing, quality management and regulatory affairs is large and will continue to grow in the next years.

To facilitate growth in the cell and gene therapy space CellGenix is proud to support the Master program in Manufacturing of Advanced Therapy Medicinal Products organized by the Andalusian Initiative for Advanced Therapies and the University of Granada with the collaboration of the Línea IAVANTE ‐ Progress and Health Foundation.


The program offers the following degrees:

Master in Manufacturing of Advanced Therapy Medicinal Products,

  • specialization as Qualified Person
  • specialization as Manufacturing Manager
  • specialization as Quality Control Manager
  • Expert in Quality Assurance
    for Manufacturing of Advanced Therapy Medicinal Products
Interested in the Master’s program?

You can find more information here:


Organized by:

With the collaboration of:

Golden Sponsor: